Genzyme Corporate Research Search Genzyme Websites
Patients and FamiliesHealth Care ProfessionalsAbout Genzyme Therapeutics
Fabry Community HomeFabry Community
Health Care Professional Overview
About Fabry Disease
Signs and Symptoms
Genetics of Fabry Disease
Diagnosing Fabry
Disease Monograph
Current Treatments
The Fabry Registry
Genzyme Support
Resources

Pain

Renal ImpactCardiac Dysfunction
Cerebrovascular ComplicationsPain
AngiokeratomasHypohidrosis/Anhidrosis
Ophthalmologic FindingsHeat and Cold Intolerance
Gastrointestinal Manifestations 

There are two types of pain common to Fabry disease: acroparesthesia and Fabry pain crises.

Acroparesthesia

Acroparesthesia occurs in the majority of hemizygotes, and in less than 10% of heterozygotes.[1] It is characterized by tingling, burning pain and discomfort in the palms of the hands and the soles of the feet.[1] The accumulation of GL-3 in the walls of blood vessels in skin tissue leads to nerve fiber degeneration. Degeneration of small myelinated and unmyelinated fibers and/or loss of small peripheral sensory neurons in the dorsal root ganglia and small fiber dysfunction are thought to contribute to the characteristic acroparesthesia in Fabry disease.[2,3]

Fabry pain crises

Fabry pain crises are episodes of acute agonizing pain, typically beginning in the extremities and radiating inward, lasting from several minutes to several days, and are often induced by emotional stress, changes in temperature, exercise, and/or fatigue.[1]

Pain crises are often one of the first symptoms experienced in Fabry disease and may lead a child to his or her first Fabry-related physician visit. Because the pain is often accompanied by fever and elevated erythrocyte sedimentation rates, it may be erroneously identified as rheumatic in origin.[4]

For a list of suggested readings on pain and other neurological complications associated with Fabry disease, click here.

References

1. Desnick RJ, Ioannou YA, Eng CM. Alpha-galactosidase A deficiency: Fabry disease. In: The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw Hill, 2001;3733-3774.

2. Ohnishi A, Dyck PJ. Loss of small peripheral sensory neurons in Fabry disease. Arch Neurol. 1974;31:120-126.

3. Hilz MJ, Stemper B, Kolodny EH. Lower limb cold exposure induces pain and prolonged small fiber dysfunction in Fabry patients. Pain. 2000;84:361-365.

4. Paira SO, Roverano S, Iribas JL, Barcelo HA. Joint manifestations of Fabry’s disease. Clin Rheumatol. 1992;11:563-565.

Keyword: 
Search In: 
New Page 1
Fabry Voices
""

More Fabry patient profiles
Resources
Medical Information Services
Request Materials
Publications
Events Calendar
Related Links
Fabry Registry

First Symptoms to Diagnosis

Data from the Fabry Registry confirms the large gap between the average age of symptoms onset (10.5) and diagnosis of Fabry disease (28.5). To learn more about the importance of the Fabry Registry click here.

Contact Information
Genzyme Therapeutics
500 Kendall Street
Cambridge, MA 02142
617 768 9000
800 745 4447

Genzyme Europe BV
Gooimeer 10
1411 DD Naarden
The Netherlands
31 35 699 1200
Contact Genzyme


Terms and Conditions of Use | Privacy Policy | © 2003-2009 Genzyme Corporation. All rights reserved.| © Fabr/US/P219/08/05
Genzyme Therapeutics